Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$atra](/topic/$atra)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$atra/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$atra/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XXX%  
**1 Month**: XX% -X%  
**1-Year High**: XXX% on 2025-04-30  
**1-Year Low**: XX% on 2025-07-18  

**Most Supportive Themes**
- **Stock Market Gains:** (60%) Positive sentiment around the potential for gains in the stock market, with multiple users reporting profits from following specific analysts or strategies.
- **ADEX Claim:** (30%) Positive sentiment around the claim of $ADEX tokens for $ASTRA holders.
- **Partnerships and Trials:** (9%) Mentions of Vertex securing Alyftrek coverage and Merck's Phase X trials.
  
**Most Critical Themes**
- **Regulatory Updates:** (1%)  Concerns about the transfer of an Investigational New Drug Application.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXXXX   | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$atra

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XXX%
1 Month: XX% -X%
1-Year High: XXX% on 2025-04-30
1-Year Low: XX% on 2025-07-18

Most Supportive Themes

  • Stock Market Gains: (60%) Positive sentiment around the potential for gains in the stock market, with multiple users reporting profits from following specific analysts or strategies.
  • ADEX Claim: (30%) Positive sentiment around the claim of $ADEX tokens for $ASTRA holders.
  • Partnerships and Trials: (9%) Mentions of Vertex securing Alyftrek coverage and Merck's Phase X trials.

Most Critical Themes

  • Regulatory Updates: (1%) Concerns about the transfer of an Investigational New Drug Application.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXXXX XX% XX X%
Total XXX XX% XXXXX XX% XX X%
$atra Sentiment
/topic/$atra/sentiment